Медицинский совет (Nov 2017)
COMBINATION THERAPY OF EROSIVE FORM OF GERD IN PATIENTS WITH THE MIXED CHARACTER OF RELUCTATE
Abstract
The article presents the result of study of the effectiveness of a new drug dexlansoprazole in combination with the drug ursodeoxycholic acid in the group of patients with erosive esophagitis, with mixed reflux, as defined by results of 24-hour pHimpedance metering. Dynamics of clinical symptoms and endoscopic pattern when taking different doses of UDCA of primary and supportive therapy is monitored.
Keywords